Skip to main content
Log in

Location of Lymph Node Involvement in Patients with Esophageal Adenocarcinoma Predicts Survival

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The location of positive lymph nodes has been abandoned in the seventh classification of the TNM staging system for esophageal adenocarcinoma. The present study evaluates whether distribution of involved nodes relative to the diaphragm in addition to TNM 7 further refines prediction.

Methods

Pathology reports of patients who underwent esophagectomy between 2000 and 2008 for adenocarcinoma of the esophagus were reviewed and staging was performed according to the seventh UICC-AJCC staging system. In addition, lymph node involvement of nodal stations above and below the diaphragm was investigated by endoscopic ultrasonography (EUS) in a separate cohort of patients who were scheduled for esophagectomy between 2008 and 2009 at two institutions. Survival was calculated by the Kaplan–Meier method, and multivariate analysis was performed with a Cox regression model.

Results

Some 327 patients who had undergone esophagectomy for cancer were included. Multivariate analysis revealed that patients with from three to six involved lymph nodes in the resection specimen on both sides of the diaphragm had a twofold higher chance of dying compared to patients with the same number of involved lymph nodes on one side of the diaphragm. EUS assessment of lymph node metastases relative to the diaphragm in 102 patients showed that nodal involvement on both sides of the diaphragm was associated with worse survival than when nodes on one side or no nodes are involved [HR (95 % CI) 2.38 (1.15–4.90)].

Conclusions

A combined staging system that incorporates distribution of lymph nodes relative to the diaphragm refines prognostication after esophagectomy as assessed in the resected specimen and pretreatment as assessed by EUS. This improved staging has the potential to have a great impact on clinical decision making as to whether to embark upon potentially curative or palliative treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tepper J, Krasna MJ, Niedzwiecki D et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26:1086–1092

    Article  CAS  PubMed  Google Scholar 

  2. Kayani B, Zacharakis E, Ahmed K et al (2011) Lymph node metastases and prognosis in oesophageal carcinoma—a systematic review. Eur J Surg Oncol 37:747–753

    Article  CAS  PubMed  Google Scholar 

  3. Sobin LH, Gospodarowicz MK, Wittekind C (2010) International Union against Cancer. TNM classification of malignant tumours, 7th edn. Wiley, Chichester

    Google Scholar 

  4. Peters CJ, Hardwick RH, Vowler SL, Fitzgerald RC, Oesophageal Cancer Clinical and Molecular Stratification Study Group (2009) Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma. Br J Surg 96:724–733

    Article  CAS  PubMed  Google Scholar 

  5. van Vliet EP, Heijenbrok-Kal MH, Hunink MG et al (2008) Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98:547–557

    Article  PubMed Central  PubMed  Google Scholar 

  6. Grotenhuis BA, Wijnhoven BPL, Poley WE et al (2013) Preoperative assessment of tumor location and station-specific lymph node status in patients with adenocarcinoma of the gastro-esophageal junction. World J Surg 37:147–155. doi:10.1007/s00268-012-1804-9

    Article  PubMed  Google Scholar 

  7. Van Hagen P, Hulshof MC, Van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 31:2074–2084

    Article  Google Scholar 

  8. Boonstra JJ, Kok TC, Wijnhoven BP et al (2011) Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer 11:181

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Sano T, Aiko T (2011) New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 14:97–100

    Article  PubMed  Google Scholar 

  10. Bhutani MS, Hawes RH, Hoffman BJ (1997) A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 45:474–479

    Article  CAS  PubMed  Google Scholar 

  11. Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662–1669

    Article  PubMed  Google Scholar 

  12. Rice TW (1999) Superficial oesophageal carcinoma: is there a need for three-field lymphadenectomy? Lancet 354:792–794

    CAS  PubMed  Google Scholar 

  13. Hosch SB, Stoecklein NH, Pichlmeier U et al (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19:1970–1975

    CAS  PubMed  Google Scholar 

  14. Cense HA, Sloof GW, Klaase JM et al (2004) Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy. J Nucl Med 45:247–252

    PubMed  Google Scholar 

  15. Steup WH, De Leyn P, Deneffe G et al (1996) Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 111:85–94

    Article  CAS  PubMed  Google Scholar 

  16. Tachimori Y, Kato H, Watanabe H et al (1996) Difference between carcinoma of the lower esophagus and the cardia. World J Surg 20:507–510. doi:10.1007/s002689900080

    Article  CAS  PubMed  Google Scholar 

  17. van de Ven C, De Leyn P, Coosemans W et al (1999) Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg 15:769–773

    Article  PubMed  Google Scholar 

  18. Lagarde SM, Cense HA, Hulscher JB et al (2005) Prospective analysis of patients with adenocarcinoma of the gastric cardia and lymph node metastasis in the proximal field of the chest. Br J Surg 92:1404–1408

    Article  CAS  PubMed  Google Scholar 

  19. Mortensen MB, Edwin B, Hunerbein M et al (2007) Impact of endoscopic ultrasonography (EUS) on surgical decision-making in upper gastrointestinal tract cancer: an international multicenter study. Surg Endosc 21:431–438

    Article  CAS  PubMed  Google Scholar 

  20. Subasinghe D, Samarasekera DN (2010) A study comparing endoscopic ultrasound (EUS) and computed tomography (CT) in staging oesophageal cancer and their role in clinical decision making. J Gastrointest Cancer 41:38–42

    Article  PubMed  Google Scholar 

  21. Barbour AP, Rizk NP, Gerdes H et al (2007) Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg 205:593–601

    Article  PubMed  Google Scholar 

  22. Natsugoe S, Yoshinaka H, Shimada M et al (2001) Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg 234:613–618

    Article  CAS  PubMed  Google Scholar 

  23. Omloo JM, Sloof GW, Boellaard R et al (2008) Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer. Endoscopy 40:464–471

    Article  CAS  PubMed  Google Scholar 

  24. Mariette C, Balon JM, Maunoury V et al (2003) Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg 90:1367–1372

    Article  CAS  PubMed  Google Scholar 

  25. Puli SR, Reddy JB, Bechtold ML et al (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14:1479–1490

    Article  PubMed  Google Scholar 

  26. Nishimura H, Tanigawa N, Hiramatsu M et al (2006) Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg 202:604–611

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Eric van de Stok, Gijsbert Hotte, and Joel Shapiro (medical researchers at the Department of Surgery, Erasmus MC, University Medical Center Rotterdam) for their assistance with the data collection.

Conflict of interest

The authors declare that there is no financial or personal relationship with people or organisations that could inappropriately bias their work. No grants or support has been given from any institute for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aaldert K. Talsma.

Additional information

Aaldert K. Talsma and Chin-Ann J. Ong contributed equally this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

268_2013_2236_MOESM1_ESM.rtf

Electronic supplementary material The online version of this article (doi: 10.1007/s00268-013-2236-x) contains supplementary material which is available to authorized users. (RTF 1263 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Talsma, A.K., Ong, CA.J., Liu, X. et al. Location of Lymph Node Involvement in Patients with Esophageal Adenocarcinoma Predicts Survival. World J Surg 38, 106–113 (2014). https://doi.org/10.1007/s00268-013-2236-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-013-2236-x

Keywords

Navigation